1. Home
  2. KPET vs TKNO Comparison

KPET vs TKNO Comparison

Compare KPET & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KPET Ultra Paceline Corporation Class A Ordinary Shares

KPET

KPET Ultra Paceline Corporation Class A Ordinary Shares

N/A

Current Price

$10.05

Market Cap

288.9M

Sector

N/A

ML Signal

N/A

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$5.53

Market Cap

268.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPET
TKNO
Founded
N/A
1996
Country
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.9M
268.1M
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
KPET
TKNO
Price
$10.05
$5.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.3K
115.2K
Earning Date
N/A
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.86
EPS
N/A
N/A
Revenue
N/A
$40,520,000.00
Revenue This Year
N/A
$8.27
Revenue Next Year
N/A
$13.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.35
52 Week Low
$9.95
$1.91
52 Week High
$10.05
$6.68

Technical Indicators

Market Signals
Indicator
KPET
TKNO
Relative Strength Index (RSI) 57.14 N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.01 0.00
MACD 0.00 0.00
Stochastic Oscillator 100.00 0.00

Price Performance

Historical Comparison
KPET
TKNO

About KPET KPET Ultra Paceline Corporation Class A Ordinary Shares

KPET Ultra Paceline Corp is a Blank Check company. It is formed with the objective of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

Share on Social Networks: